IKS Health - Public Comps and Valuation Multiples

IKS Health Overview

About IKS Health

Inventurus Knowledge Solutions Ltd is a technology enabled healthcare solutions provider, serving the U.S healthcare market. The group offer a comprehensive care enablement platform that supports healthcare enterprises across outpatient and inpatient care settings. It is operates in in Care Enablement, empowering healthcare organizations to deliver high-quality care efficiently and sustainably through an integrated platform that combines technology and deep human expertise. The Company operates in one reportable segment which is Healthcare. Its solutions are Revenue Cycle Management, Clinical Support, and Value-Based Care.

Founded

2006

HQ

Employees

7.5K+

Website

ikshealth.com

Sectors

Hospitals & Clinics

Financials

LTM Revenue $332M

LTM EBITDA $101M

EV

$2.9B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

IKS Health Financials

As of September 2025, IKS Health reported last 12-month revenue of $332M and EBITDA of $101M.

In the same period, IKS Health generated $242M in LTM gross profit and $65.5M in net income.

See IKS Health valuation multiples based on analyst estimates

IKS Health P&L

In the most recent fiscal year, IKS Health reported revenue of $300M and EBITDA of $91.1M.

IKS Health expects next 12-month revenue of XXX and NTM EBITDA of XXX

See IKS Health valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$332M	XXX	$300M	XXX	XXX	XXX
Gross Profit	$242M	XXX	$129M	XXX	XXX	XXX
Gross Margin	73%	XXX	43%	XXX	XXX	XXX
EBITDA	$101M	XXX	$91.1M	XXX	XXX	XXX
EBITDA Margin	30%	XXX	30%	XXX	XXX	XXX
EBIT	$89.3M	XXX	$74.3M	XXX	XXX	XXX
EBIT Margin	27%	XXX	25%	XXX	XXX	XXX
Net Profit	$65.5M	XXX	$54.8M	XXX	XXX	XXX
Net Margin	20%	XXX	18%	XXX	XXX	XXX
Net Debt	XXX	XXX	$64.8M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for IKS Health including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $332M. EBITDA for the last twelve months was $101M. In the most recent fiscal year, IKS Health achieved $300M in revenue and $91.1M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$332M	Analyst estimates available to subscribers	$300M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$242M	Analyst estimates available to subscribers	$129M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	72.9% gross margin	Analyst estimates available to subscribers	43.0% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$101M	Analyst estimates available to subscribers	$91.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	30.4% EBITDA margin	Analyst estimates available to subscribers	30.3% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$89.3M	Analyst estimates available to subscribers	$74.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	26.9% EBIT margin	Analyst estimates available to subscribers	24.7% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$65.5M	Analyst estimates available to subscribers	$54.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	19.7% net profit margin	Analyst estimates available to subscribers	18.2% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$64.8M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for IKS Health

This financial data table provides comprehensive performance metrics for IKS Health, a company based in India. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

IKS Health generated $332M in revenue over the last twelve months.
The company achieved $101M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $242M.
Net income over the last twelve months reached $65.5M.

Fiscal Year Performance

In the most recent fiscal year, IKS Health reported $300M in total revenue.
Fiscal year EBITDA was $91.1M.
The company maintained a gross profit margin of 43.0% in the most recent fiscal year.
EBITDA margin for the fiscal year was 30.3%.
Net profit margin reached 18.2% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for IKS Health. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

IKS Health Stock Performance

IKS Health has current market cap of INR 252B (or $2.8B), and EV of INR 259B (or $2.9B).

Market Cap Evolution

IKS Health Stock Data

As of October 17, 2025, IKS Health's stock price is INR 1508 (or $17).

See IKS Health trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$2.9B	$2.8B	XXX	XXX	XXX	XXX	$0.39

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

IKS Health Valuation Multiples

IKS Health's trades at 10.5x EV/Revenue multiple, and 34.7x EV/EBITDA.

See valuation multiples for IKS Health and 15K+ public comps

IKS Health Financial Valuation Multiples

As of October 17, 2025, IKS Health has market cap of $2.8B and EV of $2.9B.

Equity research analysts estimate IKS Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

IKS Health has a P/E ratio of 43.4x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$2.8B	XXX	$2.8B	XXX	XXX	XXX
EV (current)	$2.9B	XXX	$2.9B	XXX	XXX	XXX
EV/Revenue	8.8x	XXX	10.5x	XXX	XXX	XXX
EV/EBITDA	28.9x	XXX	34.7x	XXX	XXX	XXX
EV/EBIT	32.7x	XXX	42.4x	XXX	XXX	XXX
EV/Gross Profit	12.1x	XXX	n/a	XXX	XXX	XXX
P/E	43.4x	XXX	55.1x	XXX	XXX	XXX
EV/FCF	50.7x	XXX	103.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get IKS Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

IKS Health Margins & Growth Rates

IKS Health's last 12 month revenue growth is 19%

IKS Health's revenue per employee in the last FY averaged $40K, while opex per employee averaged $7K for the same period.

IKS Health's rule of 40 is 49% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

IKS Health's rule of X is 77% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for IKS Health and other 15K+ public comps

IKS Health Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	19%	XXX	21%	XXX	XXX	XXX
EBITDA Margin	30%	XXX	30%	XXX	XXX	XXX
EBITDA Growth	24%	XXX	24%	XXX	XXX	XXX
Rule of 40	49%	XXX	49%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	77%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$40K	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$7K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	1%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	18%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial